Coronary heart disease secondary prevention influenza vaccination

Revision as of 16:59, 14 November 2012 by Esther Lee (talk | contribs)
Jump to navigation Jump to search

Coronary heart disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Coronary heart disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening and Risk Stratification

Natural History, Complications and Prognosis

Diagnosis

Pretest Probability

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Coronary heart disease secondary prevention influenza vaccination On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Coronary heart disease secondary prevention influenza vaccination

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Coronary heart disease secondary prevention influenza vaccination

CDC on Coronary heart disease secondary prevention influenza vaccination

Coronary heart disease secondary prevention influenza vaccination in the news

Blogs on Coronary heart disease secondary prevention influenza vaccination

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Coronary heart disease secondary prevention influenza vaccination

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Influenza Vaccination

2011 AHA/ACCF Guidelines for Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease (DO NOT EDIT) [1]

Influenza Vaccination (DO NOT EDIT) [1]

Class I
"1. Patients with cardiovascular disease should have an annual influenza vaccination. [2][3][4][5] (Level of Evidence: B)"

Sources

  • 2011 AHA/ACCF Guidelines for Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Aterosclerotic Vascular Disease (DO NOT EDIT) [1]

References

  1. 1.0 1.1 1.2 Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA; et al. (2011). "AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation". Circulation. 124 (22): 2458–73. doi:10.1161/CIR.0b013e318235eb4d. PMID 22052934.
  2. Gurfinkel EP, Leon de la Fuente R, Mendiz O, Mautner B (2004). "Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study". Eur. Heart J. 25 (1): 25–31. PMID 14683739. Unknown parameter |month= ignored (help)
  3. Ciszewski A, Bilinska ZT, Brydak LB; et al. (2008). "Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study". Eur. Heart J. 29 (11): 1350–8. doi:10.1093/eurheartj/ehm581. PMID 18187561. Unknown parameter |month= ignored (help)
  4. Davis MM, Taubert K, Benin AL; et al. (2006). "Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology". Circulation. 114 (14): 1549–53. doi:10.1161/CIRCULATIONAHA.106.178242. PMID 16982936. Unknown parameter |month= ignored (help)
  5. Lindsey NP, Staples JE, Lehman JA, Fischer M (2010). "Surveillance for human West Nile virus disease - United States, 1999-2008". MMWR Surveill Summ. 59 (2): 1–17. PMID 20360671. Unknown parameter |month= ignored (help)


Template:WikiDoc Sources